SR biotek Inc. (XKON:270210)

ANSYS Statistics

Total Valuation

SR biotek has a market cap or net worth of KRW 46.35 billion.

Market Cap	46.35B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SR biotek has 1.66 million shares outstanding.

Current Share Class	1.66M
Shares Outstanding	1.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.30%
Owned by Institutions (%)	5.72%
Float	425,105

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.61
PB Ratio	85.18
P/TBV Ratio	85.29
P/FCF Ratio	2,066.70
P/OCF Ratio	295.22
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 3.15.

Current Ratio	0.78
Quick Ratio	0.45
Debt / Equity	3.15
Debt / EBITDA	5.69
Debt / FCF	76.38
Interest Coverage	1.01

Financial Efficiency

Return on equity (ROE) is -13.21% and return on invested capital (ROIC) is 1.37%.

Return on Equity (ROE)	-13.21%
Return on Assets (ROA)	1.20%
Return on Invested Capital (ROIC)	1.37%
Return on Capital Employed (ROCE)	3.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.61
Inventory Turnover	2.98

Taxes

In the past 12 months, SR biotek has paid 2.42 million in taxes.

Income Tax	2.42M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +254.88% in the last 52 weeks. The beta is 1.03, so SR biotek's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	+254.88%
50-Day Moving Average	22,672.40
200-Day Moving Average	22,006.65
Relative Strength Index (RSI)	73.62
Average Volume (20 Days)	593

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SR biotek had revenue of KRW 1.62 billion and -76.98 million in losses. Loss per share was -1,924.04.

Revenue	1.62B
Gross Profit	744.58M
Operating Income	51.55M
Pretax Income	-74.56M
Net Income	-76.98M
EBITDA	300.90M
EBIT	51.55M
Loss Per Share	-1,924.04

Balance Sheet

The company has 359.15 million in cash and 1.71 billion in debt, giving a net cash position of -1.35 billion or -817.79 per share.

Cash & Cash Equivalents	359.15M
Total Debt	1.71B
Net Cash	-1.35B
Net Cash Per Share	-817.79
Equity (Book Value)	544.07M
Book Value Per Share	13,599.45
Working Capital	-188.60M

Cash Flow

In the last 12 months, operating cash flow was 156.99 million and capital expenditures -134.56 million, giving a free cash flow of 22.43 million.

Operating Cash Flow	156.99M
Capital Expenditures	-134.56M
Free Cash Flow	22.43M
FCF Per Share	13.55

Margins

Gross margin is 45.96%, with operating and profit margins of 3.18% and -4.75%.

Gross Margin	45.96%
Operating Margin	3.18%
Pretax Margin	-4.60%
Profit Margin	-4.75%
EBITDA Margin	18.57%
EBIT Margin	3.18%
FCF Margin	1.38%

Dividends & Yields

SR biotek does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.17%
FCF Yield	0.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SR biotek has an Altman Z-Score of 0.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.8
Piotroski F-Score	3